World Antibody Congress

World Antibody Congress

The 2017 European Antibody Congress will be held 31. October – 2. November at Congress Center Basel in Switzerland.
The congress brings together a selection of industry professionals across the whole value chain, to share unique insights. The congress is co-located with the World Biosimilar Congress, World Immunotherapy Congress and HPAPI World Congress so attendance will have access to plenty of content across the 3 days and a lot of networking opportunities with over 500 leading industry professionals.

We at Novo Nordisk Pharmatech  invite you to come visit our both (both #53) to discover more about recombinant insulin for innovative biologics and pharmaceutical grade Quaternary ammonium compounds.

At Novo Nordisk Pharmatech we remain the  leading worldwide supplier of recombinant insulin. Our recombinant insulin is a key component in serum free growth media for mammalian cells and approved by regulatory bodies worldwide, including FDA and EMA, and our products are manufactured to cGMP standards, and we guarantee:

  • Global regulatory compliance
  • Consistent high quality
  • Extensive regulatory documentation
  • Continuous availability
  • Secure global supply chain
  • High levels of service and support

We deliver a proven record of product PurityReliability and Consistency and can even tailor Quality products for future therapies.


 

Increase viable CHO cell density in commercial available cell culture medium by supplementation with non-animal insulin

CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum containing to Serum free and further on to chemically defined media. UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density. In addition to this benefit insulin has been proven to aid in the expression of difficult to express proteins. Please stop by our booth for a talk how insulin could play an important role in your upstream process and for the chance to win an Amazon kindle.

Read More


If you want to learn more about our recombinant Insulin Human click here

We look forward to see you at our both and offer you a chance to discover more about our recombinant insulin for innovative biologics.

Contact

Magnus Franzmann

Sales Manager, Insulin

Email

Direct phone: +45 2429 4105